Thus, in prostate cancer cells eIF2α controls basal ATM and AMPKα protein levels and that in the absence of ATM or AMPK, the ability of the cell to cause eIF2α S51 phosphorylation is also diminished. Here, EIF2A is linked to prostate cancer.